Legacy Capital Group California, Inc. Dr Reddys Laboratories LTD Transaction History
Legacy Capital Group California, Inc.
- $301 Billion
- Q3 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 2,726 shares of RDY stock, worth $42,825. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,726
Previous 2,672
2.02%
Holding current value
$42,825
Previous $204 Million
6.39%
% of portfolio
0.07%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
245Shares Held
23.1MCall Options Held
12.7KPut Options Held
6.1K-
Morgan Stanley New York, NY2.24MShares$35.2 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.2.07MShares$32.4 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$31.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$30.6 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$28.3 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.61B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...